Literature DB >> 26370617

Cardiac Rehabilitation for Hypertension Assessment and Control: Report From the International Council of Cardiovascular Prevention and Rehabilitation.

Abraham Samuel Babu1, Sherry L Grace2,3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26370617      PMCID： PMC8031890          DOI： 10.1111/jch.12663

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  31 in total

Review 1.  Exercise-based rehabilitation for coronary heart disease.

Authors:  J A Jolliffe; K Rees; R S Taylor; D Thompson; N Oldridge; S Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Geographic distribution of cardiac rehabilitation programs in the United States.

Authors:  Daniel Y Curnier; Patrick D Savage; Philip A Ades
Journal:  J Cardiopulm Rehabil       Date:  2005 Mar-Apr       Impact factor: 2.081

Review 3.  AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services.

Authors:  Randal J Thomas; Marjorie King; Karen Lui; Neil Oldridge; Ileana L Piña; John Spertus
Journal:  J Cardiopulm Rehabil Prev       Date:  2007 Sep-Oct       Impact factor: 2.081

Review 4.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

Review 5.  Global availability of cardiac rehabilitation.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

Review 6.  Australian Cardiovascular Health and Rehabilitation Association (ACRA) core components of cardiovascular disease secondary prevention and cardiac rehabilitation 2014.

Authors:  Stephen Woodruffe; Lis Neubeck; Robyn A Clark; Kim Gray; Cate Ferry; Jenny Finan; Sue Sanderson; Tom G Briffa
Journal:  Heart Lung Circ       Date:  2015-01-12       Impact factor: 2.975

7.  Cardiac rehabilitation in Latin America.

Authors:  Claudia Victoria Anchique Santos; Francisco Lopez-Jimenez; Briseida Benaim; Gerard Burdiat; Rosalia Fernandez Coronado; Graciela Gonzalez; Arthur Herdy; Jose Medina-Inojosa; Claudio Santibañez; Juan E Uriona Villarroel; Cecilia Zeballos
Journal:  Prog Cardiovasc Dis       Date:  2014-09-16       Impact factor: 8.194

8.  International Charter on Cardiovascular Prevention and Rehabilitation: a call for action.

Authors:  Sherry L Grace; Darren R Warburton; James A Stone; Bonnie K Sanderson; Neil Oldridge; Jennifer Jones; Nathan Wong; John P Buckley
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Mar-Apr       Impact factor: 2.081

9.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.

Authors:  Gary J Balady; Mark A Williams; Philip A Ades; Vera Bittner; Patricia Comoss; Jo Anne M Foody; Barry Franklin; Bonnie Sanderson; Douglas Southard
Journal:  J Cardiopulm Rehabil Prev       Date:  2007 May-Jun       Impact factor: 2.081

10.  Cardiac rehabilitation and survival in older coronary patients.

Authors:  Jose A Suaya; William B Stason; Philip A Ades; Sharon-Lise T Normand; Donald S Shepard
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094
View more
  1 in total

1.  Evaluation of the American Association of Cardiovascular and Pulmonary Rehabilitation Exercise Risk Stratification Classification Tool Without Exercise Testing.

Authors:  Anusha G Bhat; Michel Farah; Heidi Szalai; Tara Lagu; Peter K Lindenauer; Paul Visintainer; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-07-01       Impact factor: 3.646
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.